1. Home
  2. CFFI vs MDWD Comparison

CFFI vs MDWD Comparison

Compare CFFI & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo C&F Financial Corporation

CFFI

C&F Financial Corporation

HOLD

Current Price

$77.92

Market Cap

258.7M

Sector

Finance

ML Signal

HOLD

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$17.14

Market Cap

224.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CFFI
MDWD
Founded
1927
2000
Country
United States
Israel
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
258.7M
224.6M
IPO Year
1998
2014

Fundamental Metrics

Financial Performance
Metric
CFFI
MDWD
Price
$77.92
$17.14
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$37.50
AVG Volume (30 Days)
3.9K
115.3K
Earning Date
01-27-2026
03-18-2026
Dividend Yield
2.36%
N/A
EPS Growth
38.69
N/A
EPS
8.34
N/A
Revenue
$129,291,000.00
$20,932,000.00
Revenue This Year
N/A
$6.97
Revenue Next Year
N/A
$23.59
P/E Ratio
$9.35
N/A
Revenue Growth
13.43
6.15
52 Week Low
$53.14
$14.14
52 Week High
$86.58
$22.51

Technical Indicators

Market Signals
Indicator
CFFI
MDWD
Relative Strength Index (RSI) 58.65 44.65
Support Level $77.09 $16.97
Resistance Level $78.86 $18.16
Average True Range (ATR) 1.50 0.72
MACD 0.14 -0.04
Stochastic Oscillator 71.04 17.05

Price Performance

Historical Comparison
CFFI
MDWD

About CFFI C&F Financial Corporation

C&F Financial Corp is an American bank holding company. The company through its subsidiaries offers banking and related financial services to both individuals and businesses. It operates in three business activities: Community Banking, Mortgage Banking, and Consumer Finance. It mainly provides a range of lending activities, which include residential mortgage loans, commercial real estate loans, non-prime automobile lending, land acquisition, and development loans, and consumer loans. The company generates maximum of its revenue from the Community Banking segment.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: